Page last updated: 2024-08-23

paclitaxel and Keratoderma Blennorrhagicum

paclitaxel has been researched along with Keratoderma Blennorrhagicum in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cawthon, CV; Christians, U; Erwin, M; Fedor, N; Geary, RL; Goel, E; Rayl, T; Register, TC; Saul, J; Schaff, C; Wilson, O; Yazdani, SK1
Bosch, RJ; Herrera, E; López, N; Tejera, A1

Other Studies

2 other study(ies) available for paclitaxel and Keratoderma Blennorrhagicum

ArticleYear
Pre-Clinical Investigation of Keratose as an Excipient of Drug Coated Balloons.
    Molecules (Basel, Switzerland), 2020, Mar-31, Volume: 25, Issue:7

    Topics: Angioplasty, Balloon; Animals; Antineoplastic Agents; Cardiovascular Agents; Coated Materials, Biocompatible; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Immunohistochemistry; Keratosis; Paclitaxel; Peripheral Arterial Disease

2020
[Onycholysis with hyponychium exudate secondary to chemotherapy with paclitaxel and capecitabine].
    Actas dermo-sifiliograficas, 2006, Volume: 97, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Astringents; Breast Neoplasms; Capecitabine; Deoxycytidine; Exudates and Transudates; Female; Fluorouracil; Hallux; Humans; Keratosis; Mupirocin; Nail Diseases; Ointments; Paclitaxel; Time Factors; Treatment Outcome; Zinc Sulfate

2006